Research study Program year 2025 Source: CMS Open Payments

Ocrelizumab Pregnancy Registry

Research payments

$64,044

53 payments

Through program year 2025, $64,044 in research payments was reported against Ocrelizumab Pregnancy Registry, across 53 payments, paid by Roche Products Limited.

Paid by: Roche Products Limited
ClinicalTrials.gov: No trial number was reported for this study

By program year

6 rows

Year	Kind	Amount	Payments
2025	Research	$16,192	8
2024	Research	$9,988	12
2023	Research	$15,128	17
2022	Research	$8,900	7
2021	Research	$13,337	8
2020	Research	$500	1

Breakdown

Who paid Research payments · program years 2020–2025

Roche Products Limited $64,044 53 payments

Who received the money Research payments · program years 2020–2025

Anthony R Scialli Organisation paid for research $31,025 23 payments
Brigham And Womens Hospital Teaching hospital · MA $28,957 27 payments
Angela Scheuerle Organisation paid for research $3,250 2 payments
Ag Mednet INC Organisation paid for research $812 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

3 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.